Last reviewed · How we verify

NCT07586514

A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers

Completed Phase 1
What this trial tests

Phase 1 trial testing Treatment for neuropathic pain in Neuropathic Pain in 40 participants. Completed in 18 August 2025.

Timeline
18 April 2025
18 August 2025

Quick facts

Lead sponsor4E Therapeutics
PhasePhase 1
StatusCompleted
Enrollment40
Start date18 April 2025
Estimated completion18 August 2025

Drugs / interventions tested

Conditions studied

Sponsor

4E Therapeutics

Who can join

Eligibility, any sex, with Neuropathic Pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07586514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing